Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
MedTech
J&J’s Ottava surgical robot succeeds in gastric bypass study
J&J is touting positive results from the first study of its soft-tissue surgical robot, showing the system can safely perform gastric bypass surgery.
Natalie Missakian
May 6, 2026 2:10am
J&J axes $5B CAR-T dream months after touting efficacy edge
May 1, 2026 8:26am
Johnson & Johnson teams up with Viz.ai on hematoma detection
Apr 22, 2026 9:00am
Ray shines a light on $125M round targeting genetic eye therapy
Apr 21, 2026 10:33am
J&J hands back failed gene therapy to MeiraGTx
Apr 16, 2026 10:17am
J&J launches new version of its pulsed ablation device
Apr 9, 2026 8:01am
